UNSPSC 85513335: Restriction of middle colic artery with intraluminal device, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to restriction of middle colic artery with intraluminal device, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 04V84DZ

UNSPSC 85513335 Restriction of middle colic artery with intraluminal device, percutaneous endoscopic approach is a Commodity code that shows little relevant recent activity under its nominal medical procedure scope. The recent state and local opportunities tagged to this code do not align with the procedure name: they include independent medical evaluation services for pension disability determinations, occupational medical surveillance for ferry workers, surgical benefits network curation, pharmacy benefit management, temporary health professional staffing, emergency and specialty care for detained youth, and specialty surgical center-of-excellence programs. None of these solicitations involve restriction of the middle colic artery or intraluminal device placement. The mismatch suggests either systematic miscoding or that this code's use in state and local procurement is sparse or inconsistent with its medical taxonomy definition.

The issuing bodies spanning these unrelated opportunities include the City of Phoenix Retirement Office (Arizona), the City of Long Beach (California), the Washington State Department of Transportation, Harris County Juvenile Probation Department (Texas), Collier County Board of County Commissioners (Florida), and the County of Santa Clara Health System (California). Geographic spread covers Arizona, California, Florida, Texas, and Washington. Without concrete procurement activity aligned to the code's stated scope—restriction of middle colic artery with intraluminal device—this code does not present a clear pursuit signal for firms positioned in vascular or gastrointestinal interventional services.